• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛组织中舒巴坦的新型灵敏生物测定法。

New sensitive bioassay for sulbactam in bovine tissues.

作者信息

Keeler G H, Stankewich J P, Girard A E, Rash J J

机构信息

Quality Control Division, Pfizer Inc., Groton, Connecticut 06340.

出版信息

Antimicrob Agents Chemother. 1988 Sep;32(9):1347-9. doi: 10.1128/AAC.32.9.1347.

DOI:10.1128/AAC.32.9.1347
PMID:3264131
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC175865/
Abstract

A quantitative cylinder plate bioassay for sulbactam has been developed which can detect concentrations as low as 0.01 microgram/g in bovine muscle, fat, kidney, and liver tissues. This procedure may also be applicable to human tissues and fluids. In addition to the improved sensitivity, this method differs from all previously described systems because it is based on inhibition by sulbactam of a cell-free beta-lactamase incorporated in the assay agar. The assay is unaffected by the presence of ampicillin even at concentrations 10 times that of the sulbactam concentration. This report describes the analytical technique as well as the accuracy and precision of the method. The assay can be applied to tissue depletion studies.

摘要

已开发出一种用于舒巴坦的定量圆筒平板生物测定法,该方法可检测牛肌肉、脂肪、肾脏和肝脏组织中低至0.01微克/克的浓度。该程序也可能适用于人体组织和体液。除了提高灵敏度外,该方法与所有先前描述的系统不同,因为它基于舒巴坦对掺入测定琼脂中的无细胞β-内酰胺酶的抑制作用。即使氨苄青霉素的浓度是舒巴坦浓度的10倍,该测定也不受其存在的影响。本报告描述了分析技术以及该方法的准确性和精密度。该测定法可应用于组织耗竭研究。

相似文献

1
New sensitive bioassay for sulbactam in bovine tissues.牛组织中舒巴坦的新型灵敏生物测定法。
Antimicrob Agents Chemother. 1988 Sep;32(9):1347-9. doi: 10.1128/AAC.32.9.1347.
2
[Stability of beta-lactamase inhibitors and beta-lactam antibiotics in parenteral formulations as well as in body fluids and tissue homogenates. Comparison of sulbactam, clavulanic acid, ampicillin and amoxicillin].[β-内酰胺酶抑制剂与β-内酰胺类抗生素在注射剂配方以及体液和组织匀浆中的稳定性。舒巴坦、克拉维酸、氨苄西林和阿莫西林的比较]
Arzneimittelforschung. 1991 Jan;41(1):70-3.
3
High-pressure liquid chromatographic determination of sulfamethazine residue in bovine tissue.高效液相色谱法测定牛组织中的磺胺二甲嘧啶残留量。
J Pharm Sci. 1975 Oct;64(10):1657-60. doi: 10.1002/jps.2600641014.
4
Determination of penicillin G, ampicillin, and cephapirin residues in tissues.组织中青霉素G、氨苄西林和头孢匹林残留量的测定。
J Assoc Off Anal Chem. 1983 Jan;66(1):176-9.
5
Penetration of ampicillin and sulbactam into human costal cartilage.
Infection. 1994 Mar-Apr;22(2):152-5. doi: 10.1007/BF01739028.
6
Pharmacokinetics of sulbactam and ampicillin intravenously applied in combination to healthy volunteers and patients. Determination of the ratio of the two drugs in serum and in various tissues.舒巴坦和氨苄西林联合静脉应用于健康志愿者和患者的药代动力学。血清及各组织中两种药物比例的测定。
Arzneimittelforschung. 1988 Nov;38(11):1640-3.
7
Activity of beta-lactamase inhibitor sulbactam plus ampicillin against animal isolates of Pasteurella, Haemophilus, and Staphylococcus.β-内酰胺酶抑制剂舒巴坦联合氨苄西林对巴斯德菌、嗜血杆菌和葡萄球菌动物分离株的活性。
Am J Vet Res. 1987 Dec;48(12):1678-83.
8
Beta-lactamases in clinical isolates. Spectrum implications of sulbactam/ampicillin.临床分离株中的β-内酰胺酶。舒巴坦/氨苄西林的光谱学意义。
Drugs. 1988;35 Suppl 7:12-6. doi: 10.2165/00003495-198800357-00004.
9
Role of TEM-1 β-Lactamase in the Predominance of Ampicillin-Sulbactam-Nonsusceptible in Japan.TEM-1 β-内酰胺酶在日本氨苄西林-舒巴坦不敏感中的主导作用。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.02366-18. Print 2019 Feb.
10
An evaluation of susceptibility testing methods for ampicillin-sulbactam using a panel of beta-lactamase-producing bacteria.使用一组产β-内酰胺酶细菌对氨苄西林-舒巴坦药敏试验方法的评估。
APMIS. 1999 Jul;107(7):703-8. doi: 10.1111/j.1699-0463.1999.tb01464.x.

本文引用的文献

1
Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients.小儿患者中克拉维酸钾与阿莫西林联合使用的药代动力学
Antimicrob Agents Chemother. 1982 Apr;21(4):681-2. doi: 10.1128/AAC.21.4.681.
2
Pharmacokinetics of sultamicillin in mice, rats, and dogs.舒他西林在小鼠、大鼠和犬体内的药代动力学。
Antimicrob Agents Chemother. 1984 May;25(5):599-602. doi: 10.1128/AAC.25.5.599.
3
The elimination of sulbactam alone and combined with ampicillin in patients with renal dysfunction.
J Antimicrob Chemother. 1983 Jun;11(6):583-7. doi: 10.1093/jac/11.6.583.
4
Comparative pharmacokinetics and tissue penetration of sulbactam and ampicillin after concurrent intravenous administration.同时静脉给药后舒巴坦和氨苄西林的比较药代动力学及组织穿透性
Antimicrob Agents Chemother. 1982 Apr;21(4):565-7. doi: 10.1128/AAC.21.4.565.
5
CP-45,899 in combination with penicillin or ampicillin against penicillin-resistant Staphylococcus, Haemophilus influenzae, and Bacteroides.CP - 45,899与青霉素或氨苄青霉素联合用于对抗耐青霉素的葡萄球菌、流感嗜血杆菌和拟杆菌。
Antimicrob Agents Chemother. 1980 Apr;17(4):615-22. doi: 10.1128/AAC.17.4.615.
6
Automated plate diffusion zone measurement and computerized data handling.
Bull Parenter Drug Assoc. 1973 Jul-Aug;27(4):185-94.
7
Assays of sulbactam in the presence of ampicillin.在氨苄西林存在的情况下舒巴坦的测定。
Ther Drug Monit. 1986;8(2):223-7. doi: 10.1097/00007691-198606000-00018.
8
CP-45,899, a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactams: initial bacteriological characterization.CP-45899,一种可扩展β-内酰胺类抗菌谱的β-内酰胺酶抑制剂:初步细菌学特征
Antimicrob Agents Chemother. 1978 Sep;14(3):414-9. doi: 10.1128/AAC.14.3.414.